Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on May 12, 2025

Revealing the key player in oral submucous fibrosis: could COMP be the solution?
GA, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Oral submucous fibrosis (OSF) is a serious disease that impairs mouth functionality, often leading to restricted opening and a high risk of malignant transformation. New research has uncovered a …

Iron-based nanoparticles in agriculture: promise, peril, or paradox?
GA, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- A sweeping new analysis unpacks the complex role of iron-based nanoparticles (Fe-NPs) in agriculture, revealing a delicate balance between benefit and risk. Synthesizing findings from 57 peer-reviewed …

Tiny titans at high elevations: how soil microbes sustain forest resilience
GA, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- High-altitude forest soils host microscopic communities with outsized influence on ecosystem stability. A recent study unveiled how microbial sub-communities—generalists, intermediates, and …

CMTA-INC Alliance Announces 2025 Inherited Neuropathy Fellowship Recipient
Orthopedic Surgeon to Focus on Improving Outcomes for People with CMT GLENOLDEN, PA, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) …

Prospera Energy Announces Convertible Debt Private Placement and Operations Update
CALGARY, Alberta, May 12, 2025 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) ("Prospera", “PEI” or the "Corporation") Convertible Debt Offering Prospera Energy Inc. ("Prospera" or the "Corporation") intends to raise up to $2,000,000 by …

Interim Financial Results
PERTH, Australia, May 12, 2025 (GLOBE NEWSWIRE) -- Paladin Energy Ltd (ASX:PDN, TSX:PDN, OTCQX:PALAF) (“Paladin” or the “Company”) advises that it has released its unaudited condensed interim financial report and management discussion and analysis (MD…

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright …

Finning reports Q1 2025 results, record equipment backlog
VANCOUVER, British Columbia, May 12, 2025 (GLOBE NEWSWIRE) -- Finning International Inc. (TSX: FTT) (“Finning”, the “Company”, “we”, “our” or “us”) reported first quarter 2025 results today. All monetary amounts are in Canadian dollars unless otherwise …

Douglas Dynamics Celebrates 15-Year Anniversary Listed on the New York Stock Exchange
MILWAUKEE, May 12, 2025 (GLOBE NEWSWIRE) -- Douglas Dynamics, Inc. (NYSE: PLOW), North America’s premier manufacturer and upfitter of commercial work truck attachments and equipment, today celebrated its 15th anniversary as a publicly traded company on the …

The EDR Test That Matters - AV-Comparatives to publish the first truly stealth-based EDR test
AV-Comparatives to publish the first truly stealth-based EDR test at the end of May, exposing how today’s security tools fare against APT cyberattacks. INNSBRUCK, TYROL, AUSTRIA, May 12, 2025 /EINPresswire.com/ -- AV-Comparatives, the world-renowned …

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
Hopewell, New Jersey, May 12, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …

AV-Comparatives Publishes New Consumer Cybersecurity Antivirus Test Results – May 2025
Latest Evaluations Reveal Which Cybersecurity and Antivirus Programs Truly Protect – Without Slowing You Down INNSBRUCK, TYROL, AUSTRIA, May 12, 2025 /EINPresswire.com/ -- In a time when cyberattacks are on the rise and personal data is more valuable …

Constellation Software Inc. Announces Results for the First Quarter Ended March 31, 2025 and Declares Quarterly Dividend
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) today announced its financial results for the first quarter ended March 31, 2025 and declared a $1.00 per share dividend payable on July 11, …

GINSMS Announces Financial Results for the Three Months Ended March 31, 2025
CALGARY, Alberta, May 12, 2025 (GLOBE NEWSWIRE) -- GINSMS Inc. (TSXV: GOK) (the “Corporation”) has announced its financial results for the first quarter ended March 31, 2025. The complete financial results for GINSMS are available at www.sedarplus.com. …

Microvast Reports First Quarter 2025 Financial Results
Record company Q1 revenue, increased 43.2% year over year to $116.5 million Gross margin increased from 21.2% to 36.9%, a 15.7 percentage point improvement year over year STAFFORD, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ: …

3D Systems Reports First Quarter 2025 Financial Results
ROCK HILL, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the first quarter ended March 31, 2025. Revenue of $95 million as growth in new hardware systems and related services was offset …

AirJoule Technologies Announces First Quarter 2025 Results
RONAN, Mont., May 12, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or the “Company”), the developer of the transformational AirJoule® system for separating pure water from air, today announced its first …

New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism
COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) continued to provide …

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PHILADELPHIA, May 12, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context …

BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update
Presentation at IO 360° conference showed early efficacy for Plinabulin combinations in metastatic NSCLC and Hodgkin lymphoma resistant to PD‑1/L1 therapy SEED’s first‑in‑class RBM39 degrader, reported at AACR 2025 for its total tumor regression data in …